home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Courses and Workshops  
 

Failure or OOS Investigation for environmental monitoring (viable and nonviable)

 
  August 26, 2013  
     
 
ComplianceOnline, Online Event
2013-09-05


FACT: 
Medical products are manufactured in environments that control the level of viable and non-viable particulate and to establish that the control is taking place periodic monitoring must be performed. But any time monitoring occurs there is the potential that the results will exceed limits that have been established, What actions to be taken when this occurs should be appropriate and designed to determine the cause of the limit excursion. Knowing what is appropriate is important to ensure that the investigation is performed effectively.

This presentation will review the various items that should be included in the investigation to determine the cause of the limit excursion for both viable and non-viable excursions. It will also offer some guidance on how to establish or reestablish limits that are appropriate to the specific manufacturing process. There will also be discussion on how to document the results of the investigation.

Areas Covered in the seminar:

  • What to investigate following an alert limit excursion in viable monitoring for surface or air.
  • What to investigate following an action limit excursion in viable monitoring for surface or air.
  • What actions to take based on the investigation results for viables.
  • Evaluation of limits for viables for surface and air.
  • What to investigate following an alert limit excursion in non-viable monitoring.
  • What to investigate following an action limit excursion in non-viable monitoring.
  • What actions to take based on the investigation results for non-viables.
  • Documentation of the investigation and actions.

Who will benefit:

This webinar will provide valuable information to all companies that manufacture medical products in environments that are controlled and monitored for viable or non-viable contamination.

  • QA personnel
  • Manufacturing
  • R&D
 
 
Organized by: ComplianceOnline
Invited Speakers: Gerry O’Dell, is President of Gerry O’Dell Consulting, a consulting firm based in the United States with clients around the world. Gerry O’Dell consults to medical device and pharmaceutical companies related to all the major sterilization methodologies, microbiology, environmental control, laboratory compliance, failure investigation, etc. Her varied background includes extensive knowledge in sterilization technology, laboratory management, microbiological testing (including pyrogens), decontamination of returned goods, and compliance.
 
Deadline for Abstracts: 2013-09-05
 
Registration: http://www.complianceonline.com/ecommerce/control/trainingFocus/~product_id=701354?channel=hummolgen
E-mail: referral@complianceonline.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.